← All trials
NCT04349410
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 11, 2020
- Primary completion
- Oct 11, 2020
- Completion date
- Nov 11, 2020
- First posted
- Apr 16, 2020
- Last posted
- Apr 17, 2020
- Enrollment
- 500
- Arms / groups
- 11 / —
- Source
- AACT · ingestion pipeline
Sponsors
- The Camelot FoundationLead sponsor
- The Camelot FoundationStudy chair
- The Camelot FoundationReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.